Biniszkiewicz Detlev 4
4 · iTeos Therapeutics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Biniszkiewicz Detlev
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-01-03−3,500→ 13,108 totalExercise: $19.00From: 2021-06-16Exp: 2030-07-23→ Common Stock (3,500 underlying) - Exercise/Conversion
Common Stock
2022-01-03$19.00/sh+3,500$66,500→ 3,500 total - Sale
Common Stock
2022-01-03$51.90/sh−3,500$181,650→ 0 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.